Growing community of inventors

Strasbourg, France

Renaud Legouis

Average Co-Inventor Count = 7.39

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 2

Renaud LegouisChristine Petit (4 patents)Renaud LegouisJean-Pierre Hardelin (4 patents)Renaud LegouisJean-Claude Mazie (3 patents)Renaud LegouisGenevieve Rougon (3 patents)Renaud LegouisNadia Soussi-Yanticostas (3 patents)Renaud LegouisCatherine Sarailh (3 patents)Renaud LegouisOlivier Ardouin (3 patents)Renaud LegouisGeorges Lutfalla (1 patent)Renaud LegouisJacuqeline Levilliers (1 patent)Renaud LegouisJean-Michel Claverie (1 patent)Renaud LegouisRenaud Legouis (4 patents)Christine PetitChristine Petit (13 patents)Jean-Pierre HardelinJean-Pierre Hardelin (4 patents)Jean-Claude MazieJean-Claude Mazie (12 patents)Genevieve RougonGenevieve Rougon (4 patents)Nadia Soussi-YanticostasNadia Soussi-Yanticostas (3 patents)Catherine SarailhCatherine Sarailh (3 patents)Olivier ArdouinOlivier Ardouin (3 patents)Georges LutfallaGeorges Lutfalla (6 patents)Jacuqeline LevilliersJacuqeline Levilliers (1 patent)Jean-Michel ClaverieJean-Michel Claverie (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Other (2 from 832,718 patents)

2. Institut Pasteur (2 from 869 patents)

3. The United States of America As Represented by the Department of Health (1 from 1,215 patents)

4. Centre Nationale De La Recherche Scientifique (1 from 21 patents)


4 patents:

1. 6770743 - Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuronal and neural injury

2. 6548475 - Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuronal and neural injury

3. 6121231 - Use of the KAL protein and treatment with the KAL protein in treatment

4. 5763166 - Gene associated with X linked Kallmann syndrome and diagnostic

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/13/2025
Loading…